Pfizer appoints Patrick van der Loo as Regional President for Africa and the Middle East
Pfizer has announced the appointment of Patrick van der Loo as the Regional President for Africa and the Middle East (AfME) region.
van der Loo, whose new role will be to lead commercial operations to bring scientific breakthroughs in vaccines, oncology, rare diseases, internal medicine, hospitals, and inflammation & immunology, to serve patients, noted that the contribution of the company to the fight against corona virus is a source of pride for him
“This year has made me even more grateful and proud to be part of Pfizer. The global pandemic has accentuated our purpose as a company and reinforced our commitment to patients and communities worldwide.”
He added: “AfME is home to some of the world’s fastest-growing markets with increasing demand for innovative health treatments and services. Overall, the region has shown remarkable resilience due to strong leadership and sound policies.”
He also expressed the desire to continue the company’s over 6 decades of service in the region, work with the company’s team, experts, communities and government to actualize the company’s goals.
“Pfizer has been operating for over 60 years in AfME. I look forward to continuing this journey and bringing our breakthroughs to address unmet patient needs. My top priority will remain to work with our teams to ensure greater access to our medicines across our strategic therapeutic areas.
“We will seek even stronger collaboration with healthcare professionals, communities, and governments to change the lives of millions of people and protect them from tomorrow’s health threats.”
Prior to his initial appointment as marketing manager CV leadership at Pfizer in 2005, he worked as Sales Representative at Eli Lilly, account manager at Walsh Netherlands and brand manager at Parke-Davis, he has since served in various managerial capacities for the company in Asia. He is an alumnus of Avans University of Applied Sciences.
Comment
No comments found.